Home/Filings/4/0001140361-25-002476
4//SEC Filing

Thomas Christine E 4

Accession 0001140361-25-002476

CIK 0001339005other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 7:33 PM ET

Size

9.5 KB

Accession

0001140361-25-002476

Insider Transaction Report

Form 4
Period: 2025-01-28
Thomas Christine E
Chief Reg & Clinical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-28+28,68228,682 total
    Exercise: $1.05From: 2025-01-28Exp: 2035-01-28Common Stock (28,682 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-01-28+23,60023,600 total
    Exercise: $1.05Exp: 2035-01-28Common Stock (23,600 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-01-28+55,09055,090 total
    Exercise: $1.05Exp: 2035-01-28Common Stock (55,090 underlying)
Footnotes (2)
  • [F1]The shares underlying the stock option vest equally in installments over 3 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.
  • [F2]The shares underlying the stock option vest equally in installments over 4 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.

Issuer

FEMASYS INC

CIK 0001339005

Entity typeother

Related Parties

1
  • filerCIK 0001950745

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 7:33 PM ET
Size
9.5 KB